The role of TAP and MHC class I expression in the response to melanoma immunotherapy using autologous dendritic cells (2000)

Grant type:
Princess Alexandra Hospital R&D Foundation
Researchers:
Funded by:
Princess Alexandra Hospital Auxiliary